Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Autoimmune hemolytic anemia].

H Rochant1

  • 1Commission de conciliation Hôpital Henri-Mondor 94010 Créteil. henri.rochant@hmn.ap-hop-paris.fr

La Revue Du Praticien
|January 5, 2002
PubMed
Summary
This summary is machine-generated.

Autoimmune haemolytic anaemia (AIHA) is diagnosed using the Coombs

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Characteristics of autoimmune hemolytic anemia in adults: retrospective analysis of 83 cases].

La Revue de medecine interne·2002
Same author

Quinine improves results of intensive chemotherapy (IC) in myelodysplastic syndromes (MDS) expressing P-glycoprotein (PGP). Updated results of a randomized study. Groupe Français des Myélodysplasies (GFM) and Groupe GOELAMS.

Advances in experimental medicine and biology·1999
Same author

A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes. Groupe Français des Myélodysplasies. Group Ouest-Est d'étude des Leucémies aiguës myéloïdes.

Leukemia·1999
Same author

Quinine improves the results of intensive chemotherapy in myelodysplastic syndromes expressing P glycoprotein: results of a randomized study.

British journal of haematology·1998
Same author

[Myelodysplastic syndromes: unusual and mild forms].

Pathologie-biologie·1997
Same author

Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology.

Lancet (London, England)·1996
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Area of Science:

  • Hematology
  • Immunology
  • Internal Medicine

Background:

  • Autoimmune haemolytic anaemia (AIHA) represents the earliest recognized auto-antibody mediated disease.
  • Diagnosis is simplified by the Coombs' test, despite varied clinical presentations.
  • AIHA typically manifests as warm or cold auto-antibody types, with warm types being more prevalent.

Purpose of the Study:

  • To review the clinical aspects of AIHA.
  • To explore the links between AIHA and associated diseases.
  • To highlight therapeutic challenges and future directions.

Main Methods:

  • Review of clinical features of AIHA.
  • Analysis of associations between AIHA and other conditions.
  • Evaluation of current therapeutic strategies and outcomes.

Related Experiment Videos

Main Results:

  • AIHA diagnosis is straightforward with the Coombs' test.
  • Clinical presentation varies based on auto-antibody type (warm vs. cold).
  • Over half of AIHA cases are linked to underlying immune dysregulation, including systemic disorders, lymphoid malignancies, and immunodeficiencies.

Conclusions:

  • While diagnosis is established, AIHA management remains challenging, with some patients resistant to treatment.
  • Associated conditions often reflect immune dysregulation rather than direct causation.
  • Further research into immunomodulatory therapies is crucial to restore self-tolerance and improve treatment outcomes for AIHA.